ZEZ. D. Ershebulov

Z. D. Ershebulov

*This is an algorithmically generated author record based on publicly available information.

Z. D. Ershebulov has a total of 52 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    COMPARATIVE STUDY OF ELISA STOP SOLUTIONS BASED ON MINERAL ACIDS

    by B.M. Ismagambetov, S.E. Shomanova, I.A. Akhazhanova, N.B. Esimbekova, Z.D. Ershebulov

    A comparative study of ELISA stop solutions prepared on the basis of hydrochloric, orthophosphoric and sulfuric acids was performed using a competitive ELISA model for detection of antibodies against bluetongue virus. It was demonstrated that the chemical nature and concentration of the acid significantly affect the optical density of negative (K-) and positive (K+) controls, the time-dependent change of the signal, and the ratio between negative and positive controls. Hydrochloric acid solutions within the range of 0.5-4.0 M provided a high initial signal for K- (approximately 2.0 OD units), limited optical density variation over 30 minutes (3-8%), and the highest control ratio values (50-90). Orthophosphoric acid resulted in an increase of the positive control signal over time, whereas sulfuric acid caused a decrease in both K- and K+ signals, leading to narrowing of the dynamic range. The findings confirm that the selection of the stop solution is a critical factor in ELISA standardization and directly influences the analytical reliability of the diagnostic test system.

  • Open Access

    Single Radial Immunodiffusion (SRID) Assay for Quantitative Determination of Recombinant SOD Protein in a Brucellosis Vaccine Candidate: Method Development and Validation

    by Gulnur Nakhanova, Olga Chervyakova, Kamshat Shorayeva, Aigerim Zhakypbek, Sabina Moldagulova, Aknur Ulankyzy, Alisher Omurtay, Yeraly Shayakhmetov, Temirlan Baiseit, Zharkinay Absatova, et al.

    Recombinant superoxide dismutase (SOD) protein is a promising antigen candidate for brucellosis vaccines, and its quantitative determination is essential for vaccine quality control, standardization, and regulatory compliance. Although enzyme-linked immunosorbent assay (ELISA) is widely used for antigen quantification, its application to vaccine formulations may be limited due to chemical modifications of antigenic determinants occurring during detoxification and adjuvantation processes. Therefore, alternative analytical methods, such as single radial immunodiffusion (SRID), which enable direct antigen quantification independent of antigenic determinant modifications, represent valuable tools for vaccine analysis. The aim of this study was to develop and validate a single radial immunodiffusion (SRID) assay for the quantitative determination of recombinant SOD protein and to obtain hyperimmune sera in sheep. Sheep were immunized with recombinant SOD protein formulated with aluminum hydroxide or AddaS03 adjuvants. Antibody responses were evaluated using agar gel immunodiffusion (AGID) and enzyme-linked immunosorbent assay (ELISA). Immunization with aluminum hydroxide induced higher antibody titers than AddaS03. By day 42, ELISA titers reached 1:25,600 in the aluminum hydroxide group compared with 1:3200 in the AddaS03 group. The obtained hyperimmune sera were used for SRID assay development. The optimized SRID assay demonstrated high reproducibility and specificity, with no cross-reactivity against unrelated proteins. A linear relationship was observed between the square of the precipitation ring diameter (D2) and antigen concentration (R2 = 0.956–0.989). The assay showed a limit of detection of 0.312 μg/mL, a linear range of 0.625–10 μg/mL, high precision (CV < 2%), and robustness under varying analytical conditions. The developed SRID assay represents a specific, reproducible, and robust tool for quantitative control of recombinant SOD protein in vaccine formulations.

  • MICROBIOLOGICAL MONITORING OF CLEANROOMS IN THE PRODUCTION OF STERILE PRODUCTS

    by N. B. Yesimbekova, G. K. Sheriazdan, A. M. Keramatdinova, B. D. Duisenbayev, S. M. Myrzakhan, S. S. Kubyr, A. M. Kurmantai, Z. D. Ershebulov

    The study presents the results of microbiological assessment of cleanrooms during the industrial production of foot-and-mouth disease vaccine under aseptic processing conditions. The investigations were conducted in Grade A and B areas during 2024–2025. More than 1,800 samples of air, equipment surfaces, and personnel gowning were analyzed. No microbial contamination was detected in air or on production surfaces. In 1.9% of samples taken from personnel garments and gloves, single microorganisms were identified within acceptable regulatory limits. The obtained data indicate the stability of aseptic conditions and the controlled state of the production environment.

  • Open Access

    OPTIMIZATION OF CULTIVATION CONDITIONS FOR RECOMBINANT INFLUENZA A/H5N1 STRAINS EXPRESSING BRUCELLA SPP. ANTIGENS (L7/L12, OMP16, OMP19, CU-ZN-SOD)

    by N.B. Yesimbekova, B.D. Duisenbayev, A.M. Keramatdinova, G.K. Kartbay, Z.D. Yershebulov, Sh.ZH. Ryskeldinova, Zh.S. Absatova

    The study presents the results of optimizing cultivation conditions for recombinant influenza A/H5N1 strains (NS1-truncated) expressing Brucella spp. antigens (L7/L12, OMP16, OMP19, CU-ZN-SOD). MDCK and Vero cell lines were used in the experiments. The effects of the infectious dose, incubation temperature, cultivation duration, as well as the effect of protease on viral replication, were determined. It was found that the optimal conditions for cultivating recombinant influenza A strains expressing Brucella antigens are the use of MDCK cell culture, an infectious dose of 0.01 TCID50/cell, an incubation temperature of 34.0±0.5 °C, a cultivation period of 48 hours, and addition of Trypsin-TPCK at a concentration of 1.5–2.0 μg/mL. Under these conditions, viral infectivity reached ≥5.75 log TCID50/mL, and the hemagglutination titer was 1:32. The genetic stability of the viral constructs was maintained for at least four consecutive passages. The obtained results can be used in the development and scale-up of influenza vector vaccine production technology.

  • Open Access

    SEROPREVALENCE OF ANTIBODIES TO AVIAN INFLUENZA VIRUS AND NEWCASTLE DISEASE VIRUS AMONG DOMESTIC POULTRY IN SELECTED REGIONS OF THE REPUBLIC OF KAZAKHSTAN

    by Otar Bio Pharm, В.м. Ismagambetov, D.N. Kaysenov, Сандуғаш Шоманова, I.A. Akhazhanova, N.B. Yesimbekova, K.D. Zakarya, Z.J. Ershebulov, Бекзат Исмагамбетов, Дастан Кайсенов, et al.

    The article presents the results of serological monitoring for avian influenza (AI) and Newcastle disease (ND) conducted in the Ulytau and Kostanay regionsof the Republic of Kazakhstan in 2024. The study aimed to analyze the epizootic situation based on the detection of antibodies to AI and ND viruses in samples collected from domestic poultry. The obtained data allowed for an assessment of the effectiveness of ongoing vaccination campaigns and the identification of key factors contributing to pathogen circulation within the domestic poultry population. The relevance of the study stems from the fact that AI and ND continue to pose significant threats to poultry farming, presenting risks not only to the industry's economy but also to overall biosecurity. Emerging threats of AI pandemics and epizootics, associated with high viral variability and their ability to cross species barriers, underscore the importanceof continuous monitoring of the spread of these diseases among animals and birds.The objective of the work was to analyze the epizootic situation and determine the level of seroprevalence of AI and ND viruses among domestic poultry in the Ulytau and Kostanay regions. Based on the findings, measures to optimize preventive and epizootiological activities at the regional level were proposed

  • Open Access

    SCALING COWPOX VACCINE PRODUCTION TECHNOLOGY: FROM DEVELOPMENT TO GMP STANDARDS

    by Назым Есимбекова, Жугунисов К.д., Кайсенов Д.н., Кожамкулов Е.м., Исмагамбетов Б.м., Абдураимов Е.о., Рсалиев А.с. А.с., Сихаева Н.с. Н.с., Ершебулов З.д.

    This paper presents a comprehensive analysis and systematization of the key stages of scaling the technological chain of production of cowpox vaccine, with an emphasis on the full-scale adaptation of production processes to strict criteria of good manufacturing practice (GMP). Special attention is paid to the detailed validation of all key stages, including virus cultivation, vaccine formation, lyophilization process and comprehensive quality control of the final product. Validation of key processes was carried out with careful elaboration of virus culture protocols, which included the use of the Nunc Cell Factory, ensuring high stability and reproducibility of the procedure. The introduction of improved methods of microbiological purity control at all stages of production, including regular checks for the presence of microorganisms and monitoring of environmental parameters, contributed to improving the reliability of the production process. Operational standardization was achieved through the integration of real-time systems for data monitoring and analysis, which helped minimize human error and improve production accuracy. As a result, key optimization strategies have been identified and implemented to improve production efficiency, including improving automation processes and digitalizing production lines. The results of the study represent a significant step forward in the development of veterinary vaccinology, providing a reliable basis for future developments and innovations in the field of prevention and treatment of infectious diseases in farm animals. The work highlights the importance of an interdisciplinary approach combining biological, engineering, and management competencies to achieve high standards of vaccine quality and safety. In light of the emerging challenges associated with changes in legislation and the development of new technologies, this work offers a platform for continuing research in the field of biotechnology and vaccine production aimed at adapting to the dynamic conditions of the veterinary industry.

  • Open Access

    FOOT-AND-MOUTH: ETIOLOGY, PATHOGENESIS, PREVENTION AND CONTROL MEASURES

    by N. B. Yessimbekova, B. M. Ismagambetov, Z. E. Yershebulov, З. Д. Ершебулов

    The last outbreak of foot-and-mouth disease in the Republic of Kazakhstan was detected in the East Kazakhstan region in 2013. As part of the approved FMD control strategy, the country's territory is divided into 2 free FMD zones (with and without vaccination).Specialists of the International Epizootic Bureau were invited to the republic, and the vaccines used were analyzed. And we must admit that this work has yielded certain results. Nine regions have been granted FMD-free status without vaccination. However, for the first time in many years, in January 2022, an outbreak of foot-and-mouth disease, a dangerous viral disease that can be transmitted to humans, was detected in the Karaganda region. Which crossed out almost all the work done on the way to well-being and zeroed out the chances for the development of export animal husbandry.Foot–and-mouth disease is a cross-border disease, the source of which is domestic and wild ungulates. This disease is caused by a virus of the genus Aphthovirus of the Picornaviridae family, which affects artiodactyls, both wild and domestic. Transmission of FMD virus from sick animals to other susceptible animals can occur directly or indirectly. Treatment and control of foot-andmouth disease among livestock or animals can be carried out through isolation and quarantine of sick animals, vaccination programs, biosafety measures in animal husbandry, monitoring of livestock movement and surveillance.

  • Open Access

    EPIZOOTIC LYMPHANGITIS - THE FORGOTTEN DISEASE OF UNGULATES

    by D.N. Kaisenov, N.B. Esimbekova, Z.D. Ershebulov

    Epizootic lymphangitis, as a forgotten disease of ungulates, again attracts the attention of veterinarians and zoologists. This infection, caused by pathogenic microorganisms, leads to inflammation of the lymphatic vessels, which can cause serious complications and even death of the animal. Despite the rarity of cases in recent decades, epizootic lymphangitis leaves a significant mark on the history of veterinary medicine, causing alertness among specialists. The purpose of the review. To summarize current scientific data on the etiology, pathogenesis, diagnosis and prevention of equine epizootic lymphangitis in order to assess the risk of introduction and spread of the disease to disease-free territories. Results. The review presents the epidemiological characteristics of the etiological agent of the disease, possible main and intermediate reservoirs of the pathogen in nature, mechanisms of transmission of infection, promising directions for the development of prevention and treatment tools. Conclusion. The causes of epidemics remain a mystery, but the factors contributing to the spread of the disease range from lack of vaccinations to unfavorable conditions of detention. The fight against this disease should be carried out through vaccination, isolation and quarantine of sick animals, disinfection of animal housing and equipment, as well as surveillance.